The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human study of HM95573, a novel oral RAF inhibitor, in patients with solid tumors.
 
Yong Sang Hong
No Relationships to Disclose
 
Jeeyun Lee
No Relationships to Disclose
 
Hye Sook Han
No Relationships to Disclose
 
Soo Jung Lee
No Relationships to Disclose
 
Jin-Soo Kim
No Relationships to Disclose
 
Baek-Yeol Ryoo
No Relationships to Disclose
 
Hyeong-Seok Lim
No Relationships to Disclose
 
Dae Ho Lee
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Pfizer; Samyang
 
Kyu-Pyo Kim
No Relationships to Disclose
 
Jeong Eun Kim
No Relationships to Disclose
 
Se Hoon Park
No Relationships to Disclose
 
Seung Tae Kim
No Relationships to Disclose
 
Ki Hyeong Lee
No Relationships to Disclose
 
Moon Ki Choi
No Relationships to Disclose
 
Hyesun Han
Employment - Hanmi
 
Young su Noh
Employment - Hanmi
 
Yo Han Kim
Employment - Hanmi
 
Jahoon Kang
Employment - Hanmi
 
Jeewoong Son
Employment - Hanmi
 
Tae Won Kim
Honoraria - Amgen; Lilly
Research Funding - Bayer (Inst); Merck Serono (Inst); Roche (Inst)